Over the past decade, the pharmaceutical industry has witnessed rapid growth in outsourcing services, driven by various factors including the growth of small molecules, increasing API complexities and the need to optimise costs. Here, Peter DeYoung shares his thoughts on the key trends he expects to see in the contract…
List view / Grid view
Filter the results
European Pharmaceutical Review explores how plants can be used for large-scale, glycosylated protein bioproduction for the pharma industry.
The dose CMO industry is performing strongly despite challenges of increasingly complex drug production, says a new report.
Loss of manufacturing capability as a result of regulatory non-compliance can have a devastating impact on biopharma or medical device manufacturers. In this article, Jenny Yu shares real-life examples from the industry and highlights the downstream effects of these business interruptions.
The market for containment facilities and containment manufacturing will increase in the future, due to a growing demand for oncology treatments.
Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
A market report has given a complete backdrop analysis of the pharmaceutical outsourcing market, including market growth and shares...
Boosting the safety of compounded drugs is the aim of new plan from the US Food and Drug Administration (FDA), which has unveiled a series of measures.
ProCellics™, first in-line and real-time bioprocess raman analyser, is a RESOLUTION Spectra Systems product. It offers a GMP user-friendly and easily deployed Process Analytical Technology (PAT) solution...
Provides Drug Manufacturers with Extensive Test Results for Tubing Comparison...